Endometriosis in Indian women: ICMR study points to WNT4 and CDKN2B-AS1 genetic markers newsmeter.in
Background: Endometriosis affects approximately 6-10% of women of reproductive age-an estimate that varies substantially with the diagnostic standard applied-and is increasingly recognized as a systemic inflammatory disease. Growing evidence implicates …
Endometriosis is a chronic estrogen-dependent inflammatory disorder affecting approximately 10% of women of reproductive age. It remains a major contributor to chronic pelvic pain, infertility, and reduced quality of life. …
More choice, lower costs for one million women Australian Government Department of Health, Disability and Ageing
More choice, lower costs for one million women health.gov.au
Labor seeks winning women’s health strategy The Australian
Labor seeks winning women’s health strategy theaustralian.com.au
FIFA U-20 Women’s World Cup is ‘what FIFA is there for’ – Infantino The Courier Mail
Endometriosis is a complex chronic condition, driven by estrogen, characterized by the growth of endometrial-like tissue outside the uterus. This often-debilitating disease affects millions of women globally, manifesting as severe …
Relugolix is an oral, non-peptide gonadotropin-releasing hormone receptor antagonist administered as once-daily combination therapy (relugolix-CT; 40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate) to reduce endometriosis symptoms while …